https://www.live-feeds.com/feed/new-drugs-are-replacing-chemo-for-aggressive-breast-cancerContinuously updated, source-cited coverage. https://www.live-feeds.com/feed/new-drugs-are-replacing-chemo-for-aggressive-breast-cancerhttps://www.live-feeds.com/feed/new-drugs-are-replacing-chemo-for-aggressive-breast-cancer#u20028Wed, 01 Jul 2026 10:36:10 +0000The FDA has approved Trodelvy and Datroway as first-line treatments for triple-negative breast cancer. These antibody-drug conjugates target specific proteins to deliver chemotherapy directly to tumor cells. Both drugs reduced the risk of disease progression by about 40% compared to standard chemotherapy.What's confirmed:The FDA approved Trodelvy for first-line triple-negative breast cancer.Trodelvy can be used alone or in combination with Keytruda for first-line triple-negative breast cancer.Datroway, developed by AstraZeneca and Daiichi Sankyo, was approved for a similar group of patients in